ArticleClinical kidney journal2015

A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study.

Jorge Rojas-Rivera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.